Free Trial

National Bank of Canada FI Sells 5,330 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background
Remove Ads

National Bank of Canada FI decreased its holdings in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 16.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,790 shares of the company's stock after selling 5,330 shares during the period. National Bank of Canada FI's holdings in Molina Healthcare were worth $7,797,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Public Sector Pension Investment Board raised its holdings in shares of Molina Healthcare by 13.5% during the third quarter. Public Sector Pension Investment Board now owns 2,527 shares of the company's stock worth $871,000 after acquiring an additional 300 shares in the last quarter. Tributary Capital Management LLC grew its position in Molina Healthcare by 76.1% in the fourth quarter. Tributary Capital Management LLC now owns 4,190 shares of the company's stock worth $1,219,000 after acquiring an additional 1,811 shares in the last quarter. Everence Capital Management Inc. bought a new position in shares of Molina Healthcare during the 4th quarter valued at $544,000. Smartleaf Asset Management LLC boosted its holdings in Molina Healthcare by 123.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 347 shares of the company's stock worth $100,000 after purchasing an additional 192 shares in the last quarter. Finally, SYM FINANCIAL Corp acquired a new stake in shares of Molina Healthcare in the fourth quarter worth about $249,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Molina Healthcare Stock Performance

NYSE:MOH traded up $0.04 during mid-day trading on Thursday, reaching $340.13. 142,833 shares of the company's stock were exchanged, compared to its average volume of 648,419. Molina Healthcare, Inc. has a one year low of $262.32 and a one year high of $383.58. The business's fifty day simple moving average is $309.45 and its two-hundred day simple moving average is $308.20. The firm has a market capitalization of $18.61 billion, a PE ratio of 16.69, a price-to-earnings-growth ratio of 1.06 and a beta of 0.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62.

Remove Ads

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Insider Activity at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the business's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now directly owns 17,375 shares in the company, valued at approximately $5,235,608.75. The trade was a 5.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.10% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

MOH has been the subject of several recent analyst reports. Stephens reaffirmed an "equal weight" rating and set a $345.00 price objective on shares of Molina Healthcare in a report on Thursday, February 6th. Truist Financial cut their price target on Molina Healthcare from $370.00 to $340.00 and set a "buy" rating for the company in a report on Wednesday, February 19th. StockNews.com lowered shares of Molina Healthcare from a "buy" rating to a "hold" rating in a research report on Thursday, April 3rd. UBS Group dropped their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. Finally, Guggenheim initiated coverage on Molina Healthcare in a research report on Wednesday. They issued a "neutral" rating for the company. Eight analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $350.75.

Check Out Our Latest Stock Analysis on Molina Healthcare

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Read More

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads